[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"trial:NCT01517425":3,"trial-entities:NCT01517425":55,"trial-summary:NCT01517425":58},{"id":4,"nct_id":4,"org_study_id":5,"brief_title":6,"official_title":6,"overall_status":7,"completion_date":8,"status_verified_date":9,"last_update_date":10,"start_date":11,"sponsor_name":12,"lead_sponsor_class":13,"has_dmc":14,"brief_summary":15,"detailed_description":16,"conditions":17,"keywords":19,"study_type":20,"primary_purpose":16,"phases":21,"enrollment_info":22,"interventions":25,"primary_outcomes":26,"secondary_outcomes":31,"sex":32,"minimum_age":33,"maximum_age":16,"healthy_volunteers":34,"eligibility_criteria":35,"std_ages":39,"locations":42,"central_contacts":51,"overall_officials":52,"references":53,"see_also_links":54},"NCT01517425","11-5676","Evaluating Cardiovascular Phenotypes Using Induced Pluripotent Stem Cells","ENROLLING_BY_INVITATION","2030-07","2025-01","2025-01-16","2012-11","Scripps Translational Science Institute","OTHER",false,"This research is being done to understand how changes in DNA may put people at risk for developing coronary artery disease. Stem cells will be made using cells from blood and\u002For skin biopsy samples. We are trying to understand which specific changes in DNA negatively impact a person's health.",null,[18],"Coronary Artery Disease",[],"OBSERVATIONAL",[],{"count":23,"type":24},200,"ESTIMATED",[],[27],{"measure":28,"description":29,"timeFrame":30},"iPSC development","Develop methods of iPSC generation from patients with genomic risk.","five years",[],"ALL","18 Years",true,{"inclusion":36,"exclusion":37,"raw_text":38},[],[],"Inclusion Criteria:\n\nCases:\n\n1. Previously enrolled in the CAD module of the Genebank at Scripps Clinic Registry\n2. Eligible to have their blood drawn\n3. Be reliable, cooperative and willing to comply with all protocol-specified procedures\n4. Able to understand and grant informed consent\n\nControls:\n\n1. Previously enrolled in the Healthy Elderly Active Longevity (HEAL) Cohort\n2. Eligible to have their blood drawn\n3. Be reliable, cooperative and willing to comply with all protocol-specified procedures\n4. Able to understand and grant informed consent\n\nExclusion Criteria:\n\n1. Unwilling or unable to grant informed consent.\n2. Have a significant medical condition that in the Investigator's opinion may interfere with subject's study participation.",[40,41],"ADULT","OLDER_ADULT",[43],{"facility":12,"city":44,"state":45,"zip":46,"country":47,"geoPoint":48},"La Jolla","California","92037","United States",{"lat":49,"lon":50},32.84727,-117.2742,[],[],[],[],{"nct_id":4,"conditions":56,"biomarkers":57},[18],[],{"nct_id":4,"found":14,"summary":16,"prompt_version":16}]